Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;20(4):1073-1079.
doi: 10.1111/jocd.13763. Epub 2020 Oct 27.

Dermatologic adverse reactions to proton-pump inhibitors: A synthetized review

Antoine Salloum  1   2 , Dayana Nasr  2 , Diane Maalouf  1   2
Affiliations
Review

Dermatologic adverse reactions to proton-pump inhibitors: A synthetized review

Antoine Salloum et al. J Cosmet Dermatol. 2021 Apr.

Abstract

Background: Proton-pump inhibitors (PPIs) are one of the most prescribed drugs. Their dermatological adverse reactions are multiple and vary in severity.

Aims: This review discusses all reported cutaneous side effects of PPIs in order to help physicians understand them and provide appropriate management.

Methods: A thorough search of PubMed, Embase, and FDAAQ8 drugs websites was conducted. 56 articles including case reports, case series, and review articles of PPI-induced cutaneous adverse reactions were selected. Data were recorded regarding patient age, gender, history, clinical manifestations, diagnostic tests, management, and clinical outcomes.

Results: PPI-induced adverse skin reactions are mostly immunological and include both immediate and delayed-type hypersensitivity reactions. These reactions are sometimes life-threatening. All PPIs can induce immediate IgE-mediated reactions. Most of previously published cases of delayed-type hypersensitivity reactions have involved esomeprazole, omeprazole, and lansoprazole. Skin tests are helpful in confirming PPI-induced hypersensitivity reactions and diagnosing potential cross-reactivities. PPIs should also be added to our list of usual suspects when considering possible culprits for a new presentation of drug-induced subacute lupus erythematosus. PPI-related occupational contact dermatitis has also been numerously reported.

Conclusion: PPIs should be considered in our list of culprits when considering a patient with a cutaneous drug reaction, taking into account that these drugs can cause severe immunological manifestations.

Keywords: adverse reaction; allergy; hypersensitivity; proton-pump inhibitors; rash.

PubMed Disclaimer

References

REFERENCES

    1. Pérez Pimiento AJ, Prieto Lastra L, Rodríguez Cabreros MI, González Sánchez LA, Mosquera MR, Cubero AG. Hypersensitivity to lansoprazole and rabeprazole with tolerance to other proton pump inhibitors. J Allergy Clin Immunol. 2006;117(3):707-708.
    1. Ishizaki T, Horai Y. Review article: cytochrome P450 and the metabolism of proton pump inhibitors emphasis on rabeprazole. Alimentary Pharmacol Ther. 1999;13(s3):27-36.
    1. Lobera T, Navarro B, Del Pozo MD, et al. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol. 2009;19(1):57.
    1. Bose S, Guyer A, Long A, Banerji A. Evaluation and management of hypersensitivity to proton pump inhibitors. Ann Allergy Asthma Immunol. 2013;111(6):452-457.
    1. Tourillon C, Mahe J, Baron A, et al. Immediate-type hypersensitivity cross-reactions to proton pump inhibitors: a descriptive study of data from the French national pharmacovigilance database. Int Arch Allergy Immunol. 2019;178(2):159-166.

Substances

LinkOut - more resources